Delivery Order SPE2DB22D3301-SPE2DB24FY6NL

Award Date 5/10/24
Potential Completion Date 5/13/24
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,070.94 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, an established pharmaceutical distributor. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the agency to efficiently procure a wide range of essential pharmaceutical products and medical supplies for the Department of Defense worldwide. The current...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,895.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, with a completion date of February 1, 2024. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp,...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,756.52 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide AIMOVIG 140 MG/ML autoinjector medication. The order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
The U.S. Defense Logistics Agency (DLA) awarded a $1,140.48 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AIMOVIG 140 MG/ML autoinjectors. The delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary vehicle for...
The Defense Logistics Agency (DLA) awarded a $3,615.28 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the provision of AIMOVIG 70 MG/ML AUTOINJECTORML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $1,245.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the provision of the drug AIMOVIG 140 MG/ML AUTOINJECTORML. This is a firm fixed price delivery order with a completion date of March 21, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with a potential...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, to provide AIMOVIG 140 mg/mL autoinjectors. The $1,357.86 firm-fixed-price contract has a completion date of July 10, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a broad range of pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The $1,914.60 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AIMOVIG 140 MG/ML AUTOINJECTOR. The $5,107.21 contract has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract awarded solely to...
The Defense Logistics Agency (DLA) awarded a $14,130.61 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY6NL
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,933.20 firm-fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. This order is for 4,564,572,430 units of the pharmaceutical product AIMOVIG 70 MG/ML AUTOINJECTORML. The order has a completion date of May 13, 2024. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical as the primary vehicle for delivering a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also has a smaller $750,000 indefinite delivery contract with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This latest award was made on a full and open competition basis without any set-aside designation.

Generated 8/9/24, 9:15 AM